Pulmatrix, Inc. Skyrocketed
Pulmatrix, Inc. (PULM:NASDAQ) soared at $4.7, representing a gain of 31.7%. On Thu, Nov 14, 2024, PULM:NASDAQ hit a New 2-Week High of $4.7. The stock appeared on our News Catalysts scanner on Wed, Nov 13, 2024 at 11:21 AM in the 'MERGER' category. From Thu, Oct 31, 2024, the stock recorded 40.00% Up Days and 36.36% Green Days
The stock spiked on Thu, Nov 14, 2024 at $7.87 with a volume of 14M+.
About Pulmatrix, Inc. (PULM:NASDAQ)
Pulmatrix Inc is is a clinical stage biotechnology company. The Company is engaged in discovery and development of a novel class of inhaled therapeutic products intended to prevent and treat respiratory diseases and infections.
Top 10 Gainers:
- AgEagle Aerial Systems, Inc. (UAVS:NYSEMKT), 122.36%
- Molecular Templates, Inc. (MTEM:NASDAQ), 89.38%
- VivoPower International PLC (VVPR:NASDAQ), 70.89%
- Omeros Corporation (OMER:NASDAQ), 65.87%
- Akso Health Group (AHG:NASDAQ), 58.67%
- Adagio Medical Holdings Inc (ADGM:NASDAQ), 54.58%
- X4 Pharmaceuticals, Inc. (XFOR:NASDAQ), 47.85%
- Innovation Beverage Group Limited (IBG:NASDAQ), 39.75%
- Pulmatrix, Inc. (PULM:NASDAQ), 31.65%
- Agrify Corporation (AGFY:NASDAQ), 30.49%